NanoViricides
Open
$1.24
Prev. Close
$1.24
High
$1.24
Low
$1.24
Market Snapshot
$26.35M
-3.3
-0.72
7
The company is headquartered in Shelton, Connecticut and currently employs 7 full-time employees. The company went IPO on 2004-08-12.
The company is headquartered in Shelton, Connecticut and currently employs 7 full-time employees. The company went IPO on 2004-08-12.
Recently from Cashu
NanoViricides (NYSE: NNVC): The Tiny Biotech Aiming to Tackle Big Viral Threats—Could It Be an Undervalued Opportunity?
https://firebasestorage.googleapis.com/v0/b/cashuapplication.appspot.com/o/o102g_Screen%20Shot%202025-08-06%20at%2012.10.02%20am.png?alt=media&token=d8c34ff8-51e7-4655-b064-e09cbbf3fdbd body { font-fa…
Why NanoViricides (NNVC) Could Be a $6 Stock — And Why Investors Are Starting to Notice
The Next Big Winner in Antiviral Treatments? While many investors focus on AI or electric vehicles, a small biotech company is working on something more personal: stopping viruses before they infect y…
The Tiny Biotech Aiming to Disrupt the $80 Billion Antiviral Market: Why NanoViricides (NNVC) Deserves a Closer Look
https://www.youtube.com/watch?v=7HH6cHZZtxI In the high-stakes world of antiviral drug development, big pharma dominates the headlines. But beneath the surface, an under-the-radar small-cap is quietly…
Could This Tiny Biotech Be the Key to Stopping a Measles Comeback?
Could This Tiny Biotech Be the Key to Stopping a Measles Comeback? The Measles Problem Is Back — And Getting Worse Measles, once nearly eradicated in the U.S., is making an alarming return. Thanks to…